Alessandro Posa

Dr. Alessandro Posa


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 August 2019 in World Journal of Gastroenterology
Verified
Journal Article
Open access
RIRiccardo Inchingolo
Riccardo Inchingolo
Alessandro PosaAlessandro Posa
Alessandro Posa
MMMartin Mariappan
Martin Mariappan
SSStavros Spiliopoulos
Stavros Spiliopoulos
Locoregional treatments for hepatocellular carcinoma: Current evidence and future directions

1 January 2016 in World Journal of Gastroenterology
Verified
Journal Article
Open access
RIRoberto Iezzi
Roberto Iezzi
MPMaurizio Pompili
Maurizio Pompili
Alessandro PosaAlessandro Posa
Alessandro Posa
GCGiuseppe Coppola
Giuseppe Coppola
AGAntonio Gasbarrini
Antonio Gasbarrini
LBLorenzo Bonomo
Lorenzo Bonomo
In recent years, a combination of intervention therapies has been widely applied in the treatment of hepatocellular carcinoma (HCC). One such combined strategy is based on the combination of the percutaneous approach, such as radiofrequency ablation (RFA), and the intra-arterial locoregional approach, such as trans-arterial chemoembolization (TACE). Several types of evidence have supported the feasibility and benefit of combined therapy, despite some studies reporting conflicting results and outcomes. The aim of this review was to explain the technical aspects of different combined treatments and to comprehensively analyze and compare the clinical efficacy and safety of this combined treatment option and monotherapy, either as TACE or RFA alone, in order to provide clinicians with an unbiased opinion and valuable information. Based on a literature review and our experience, combined treatment seems to be a safe and effective option in the treatment of patients with early/intermediate HCC when surgical resection is not feasible; furthermore, this approach provides better results than RFA and TACE alone for the treatment of large HCC, defined as those exceeding 3 cm in size. It can also expand the indication for RFA to previously contraindicated “complex cases”, with increased risk of thermal ablation related complications due to tumor location, or to “complex patients” with high bleeding risk.

1 September 2017 in Journal of Vascular and Interventional Radiology
Verified
Journal Article
Closed access
Roberto IezziRoberto Iezzi
Roberto Iezzi
MPMaurizio Pompili
Maurizio Pompili
Alessandro PosaAlessandro Posa
Alessandro Posa
EAEleonora Annicchiarico
Eleonora Annicchiarico
MGMatteo Garcovich
Matteo Garcovich
CCCesare Colosimo
Cesare Colosimo

31 August 2018 in European Radiology
Verified
Journal Article
Closed access
PDF file
TGthe HepatoCatt Study Group
the HepatoCatt Study Group
Roberto IezziRoberto Iezzi
Roberto Iezzi
MPMaurizio Pompili
Maurizio Pompili
Rinninella EmanueleRinninella Emanuele
Rinninella Emanuele
EAEleonora Annicchiarico
Eleonora Annicchiarico
RMRiccardo Manfredi
Riccardo Manfredi

1 November 2017 in Journal of Vascular and Interventional Radiology
Verified
Journal Article
Closed access
ASAntonio Saviano
Antonio Saviano
RIRoberto Iezzi
Roberto Iezzi
FGFELICE GIULIANTE
FELICE GIULIANTE
LSLucia Salvatore
Lucia Salvatore
CMCaterina Mele
Caterina Mele
AGAntonio Gasbarrini
Antonio Gasbarrini

Verified
Journal Article
Open access
PDF file
CLChiara Lauri
Chiara Lauri
Roberto IezziRoberto Iezzi
Roberto Iezzi
MRMichele Rossi
Michele Rossi
Giovanni TinelliGiovanni Tinelli
Giovanni Tinelli
SSSimona Sica
Simona Sica
Yamume TshombaYamume Tshomba
Yamume Tshomba
Vascular graft infection (VGI) is a rare but severe complication of vascular surgery that is associated with a bad prognosis and high mortality rate. An accurate and prompt identification of the infection and its extent is crucial for the correct management of the patient. However, standardized diagnostic algorithms and a univocal consensus on the best strategy to reach a diagnosis still do not exist. This review aims to summarize different radiological and Nuclear Medicine (NM) modalities commonly adopted for the imaging of VGI. Moreover, we attempt to provide evidence-based answers to several practical questions raised by clinicians and surgeons when they approach imaging in order to plan the most appropriate radiological or NM examination for their patients.